Trial Profile
A study to compare the abciximab and tirofiban for the treatment of thromboembolism during coil embolization of intracranial aneurysm.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Abciximab (Primary) ; Tirofiban (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- 06 Dec 2015 New trial record